THE LATEST WORD

Top Industry Stories – September 17, 2010

Posted on September 17th, 2010 | by Rxmedyn | No Comments »

Doctor And Patient – Teaching Doctors About Food and Diet

Drug-Resistant ‘Superbugs’ Hit 20 States, Spread Worldwide

Whooping Cough Data from State Show Babies Hardest Hit, Epidemic Worst Since 1955

Stem Cell Uncertainty Delays Research

Swiss Gov’t Rejects Call To Ban Assisted Suicide

Read the rest of this entry »

Top Industry Stories – September 16, 2010

Posted on September 16th, 2010 | by Rxmedyn | No Comments »

Phys Ed: Can Exercise Make Kids Smarter?

Scottish Smoking Ban Cuts Childhood Asthma Attacks

Low-Dose Aspirin Taken Daily Cuts Colon Cancer Risk, Study Says

PR Message Getting Lost To 48% Of Media, Study Says

A New Artificial Ovary May Someday Boost Women’s Success With In Vitro

Top Industry Stories – September 15, 2010

Posted on September 15th, 2010 | by Rxmedyn | No Comments »

A New Name For High-Fructose Corn Syrup

Insuring Your Health: What Will Change Under The New Law

Medical Groups Urge Flu Shots For Pregnant Women

States Opposed To Healthcare Overhaul Pin Hopes On Florida Court Hearing

Working While Sick? Study Finds Even Doctors Do It

Top Industry Stories – September 14, 2010

Posted on September 14th, 2010 | by Rxmedyn | No Comments »

Asthma Drug Albuterol Improves Multiple Sclerosis When Added To Conventional Treatment

Researchers Develop Test For Pregnancy Complication

New Drug-Resistant Superbugs Found In 3 States

Gilead’s HIV ‘Quad’ Drug Fares Well In Study

Top Industry Stories – September 13, 2010

Posted on September 13th, 2010 | by Rxmedyn | No Comments »

Stem Cell Face-Lifts On Unproven Ground

Website Offers 20-20 Vision On Women’s Health

Growing Problem Of Fake Drugs Hurting Patients, Companies

PR Takeover Fever Set To Continue Into The Fall

Social Networks And The Influence We Have On Others’ Health Behaviors

Read the rest of this entry »

Top Industry Stories – September 10, 2010

Posted on September 10th, 2010 | by Rxmedyn | No Comments »

Stem Cell Financing Ban Ends, For Now

Brain-Age Scans Seen As Potential Gauge of Child Development

U.S. Health Law Won’t Curb Growth in Spending This Decade

About.com Users Find Drug Ads More Helpful in 2010, Survey Says

Two Gene Mutations Mark Deadly Ovarian Cancer

Read the rest of this entry »

Top Industry Stories – September 9, 2010

Posted on September 9th, 2010 | by Rxmedyn | No Comments »

Nasal Allergies May Affect Infants Too

Half of ‘Untreatable’ Asthma Cases May Be Treatable

Growing Appreciation for P.R. on Madison Avenue

Discovery of  Gene Mutations May Be Key Vs. Ovarian Cancer

Alarms on Youth Obesity in Mass.

Read the rest of this entry »

Top Industry Stories – September 8, 2010

Posted on September 8th, 2010 | by Rxmedyn | No Comments »

Consumer Reports Is Rating Surgical Groups

Health Insurers Plan Hikes

Bristol-Myers Agrees to Acquire Biotech Company ZymoGenetics

Drug-Patent Decision Stands

Pediatricians Will Join For Mandatory Flu Shots

Federal Judge Continues To Dis Human Embryonic Stem Cell Research

Wyeth Paid Writers To Promote Hormone Therapy: Study

Cheaper HIV Treatment From Boehringer Beats Abbott’s in Infants

Business Confidence Higher In Pharma Sector – Report

Actavis Plots Entry Into Biosimilars With Bioton Pact

Top Industry Stories – September 3, 2010

Posted on September 3rd, 2010 | by Rxmedyn | No Comments »

Employers Push Costs for Health on Workers

Experimental Novartis Drug Shows Malaria Promise

Prescription Drug Use Rose to Include Half of Americans in 2008

Pharma (Slowly) Goes Digital

Allergan Drops FDA Lawsuit as Part of Off-Label Settlement

Read the rest of this entry »

Top Industry Stories – September 2, 2010

Posted on September 2nd, 2010 | by Rxmedyn | No Comments »

Child’s Ordeal Shows Risks of Psychosis Drugs for Young

Finding Suggests New Aim for Alzheimer’s Drugs

 Diet Drug Meridia Raises Heart Attack, Stroke risk

Diabetes Drug May Keep Lung Cancer at Bay

New Test Can Diagnose Tuberculosis in Under 2 Hours

Read the rest of this entry »